MELANIE NUTTER: Open Payments
NPI 1609843200 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 40 payments from 9 companies in 2025. Trend: 2023 $494 · 2024 $710 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $292 |
| Janssen Biotech, Inc. | 4 | $74 |
| PFIZER INC. | 3 | $46 |
| Ardelyx, Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| QOL Medical, LLC | 1 | $19 |
| Celltrion USA Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: RINVOQ, TREMFYA, XELJANZ, IBSRELA, DUPIXENT, CREON, SKYRIZI, EOHILIA.
Industry payments across LA — which companies pay providers there.
